TRex Bio, Inc.

• Eli Lilly Discloses Investment at TRex Bio with 19.9% Stake
  TradingView · 16 Oct 2026
• Form 4 TRex Bio: Joel S. Marcus (Director) For: 13 October
  Investing.com India · 14 Oct 2026
• Number of employees of TRex Bio, Inc. – NASDAQ:TRXB
  TradingView · 12 Oct 2026
• TRex Bio raises $117M in Nasdaq IPO at $14 a share
  Dealroom · 09 Oct 2026
• TRex Bio prices $117M IPO to support immune drug work
  BioPharma Dive · 09 Oct 2026
• TRex Bio, Clinical-Stage Immunology Biopharma, Files for Nasdaq Global Select Market IPO
  TradingView · 09 Oct 2026
• Lilly-backed TRex rakes in $117M IPO, while hypertension biotech Retension reveals $45M listing
  Fierce Biotech · 09 Oct 2026
• TRex Bio, Inc. Financial Statements – NASDAQ:TRXB
  TradingView · 08 Oct 2026
• TRex Bio, Inc. Income Statement – NASDAQ:TRXB
  TradingView · 08 Oct 2026
• TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public
  Fierce Biotech · 06 Oct 2026
• Immunology startup TRex Bio sets price range for $133 million public debut
  Investing.com · 05 Oct 2026
• In test of investors' appetite, Lilly-connected TRex Bio plots $153 million IPO
  The Business Journals · 05 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →